Phraction Management’s Barrick Mining B Stock Holding History

Phraction Management’s Portfolio B Stock Details B Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,150	Closed	-$234K	–	71
2025 Q3	$234K	Sell	7,150 -26,850	-79%	-$680K	0.07%	64
2025 Q2	$708K	Buy	+34,000	New	+$665K	0.23%	53

Other funds holding B

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Phraction Management's B Position: Q4 2025 in Review

Phraction Management sold out of Barrick Mining (B) in Q4 2025, closing a stake of 7,150 shares — an estimated $234K sold.

Phraction Management first reported a position in B in Q2 2025 and held it in 2 quarters. The position peaked at $708K in Q2 2025. 1,019 funds tracked by Wall St. Rank hold B as of Q4 2025.

Phraction Management reported no remaining Barrick Mining position as of Q4 2025 after selling out during the quarter.
Phraction Management sold 7,150 Barrick Mining shares in Q4 2025, an estimated $234K.
Phraction Management first reported a position in Barrick Mining in Q2 2025 and held it in 2 quarters.
Phraction Management's Barrick Mining position peaked at $708K in Q2 2025.
1,019 funds tracked by Wall St. Rank held Barrick Mining as of Q4 2025.

Based on Phraction Management's 13F filing for Q4 2025, filed 26 Jan 2026.